2009 Tour de France - Doping

Doping

In the 2009 Tour, Doping controls were conducted by the UCI, with the French body AFLD shadowing the process. Officials targeted top riders like Lance Armstrong and Alberto Contador with an unprecedented amount of tests. While the Armstrong-Contador conflict ruled the headlines, reporting on doping rather took a back seat during the race. The news that Giro runner-up Danilo Di Luca had a positive A probe in the Giro did not change that. Five days after the race finished the UCI announced that that initial Stage 16 winner Mikel Astarloza tested positive for EPO in an out-of-competition test on 26 June, eight days before the race started. Later, Astarloza was removed from the results, and the stage win transferred to Sandy Casar.

Just days before the 2010 Giro d'Italia, 2009 Giro podium finisher and King of the Mountains winner in this Tour Franco Pellizotti was announced by the UCI as a rider of interest in their biological passport program. He was sidelined by his team, and did not race again in 2010. The case was not fully resolved until March 2011, at which time the Court of Arbitration for Sport ordered Pellizotti banned for two years, to pay a fine and court costs, and have all his 2009 results vacated.

In October 2012, Lance Armstrong had all his results post 1998, including the 2009 Tour, voided by the UCI following the USADA investigation into systematic doping.

Read more about this topic:  2009 Tour De France